TEVA

Teva Pharmaceutical Industries Limited

A maker of generic medicines, biosimilars, and brand-name drugs, Teva is one of the world's largest generic drugmakers. Its products treat conditions like multiple sclerosis (COPAXONE), migraine (AJOVY), and Huntington's chorea (AUSTEDO), used by patients and health systems worldwide. Founded in 1901 in Jerusalem as a small medicine wholesaler that shipped goods by mule and camel, it took the name "Teva"—the Hebrew word for "nature"—in the 1930s.

ADRUnderlying: TEVACUSIP: 881624209HealthcareIL5 holders

American Depositary Receipt (ADR) representing 1 ordinary share of Teva Pharmaceutical Industries Ltd

Ownership Activity Financials Filings

Holder	Schedule	% of class	Shares	Filed
Migdal Insurance & Financial Holdings Ltd	13GPassive	5.37%	61.69M	Feb 17, 2026
Harel Insurance Investments & Financial Services Ltd	13G/APassive	6.3%	72.33M	Feb 9, 2026
FMR LLC	13G/APassive	2.1%	24.64M	Nov 5, 2025
Abigail P. Johnson	13G/APassive	2.1%	24.64M	Nov 5, 2025
Phoenix Financial Ltd.	13GPassive	5%	57.38M	Jul 22, 2025
Menora Mivtachim Holdings Ltd	13GPassive	5%	57.40M	Jul 17, 2025

TEVA

TEVA

Schedule 13D / 13G filings